GETINGE LIFE SCIENCE FRANCE : revenue, balance sheet and financial ratios

GETINGE LIFE SCIENCE FRANCE is a French company founded 40 years ago, specialized in the sector Fabrication d'emballages en matières plastiques. Based in VENDOME (41100), this company of category ETI shows in 2024 a revenue of 130.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GETINGE LIFE SCIENCE FRANCE (SIREN 333707669)
Indicator 2024 2023 2022 2021 2020 2019 2017 2016
Revenue 130 031 091 € 126 507 073 € 151 690 026 € 155 302 391 € 90 790 698 € 74 862 249 € 63 896 173 € 54 069 866 €
Net income 21 681 026 € 11 586 662 € 24 543 293 € 32 957 460 € 17 490 048 € 9 778 045 € 9 853 736 € 4 763 782 €
EBITDA 32 635 570 € 25 653 459 € 38 719 148 € 51 171 649 € 29 231 306 € 17 455 055 € 17 722 381 € 9 045 646 €
Net margin 16.7% 9.2% 16.2% 21.2% 19.3% 13.1% 15.4% 8.8%

Revenue and income statement

In 2024, GETINGE LIFE SCIENCE FRANCE achieves revenue of 130.0 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +11.6%. Vs 2023: +3%. After deducting consumption (39.4 M€), gross margin stands at 90.6 M€, i.e. a rate of 70%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 32.6 M€, representing 25.1% of revenue. Positive scissor effect: EBITDA margin improves by +4.8 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 21.7 M€, i.e. 16.7% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

130 031 091 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

90 598 969 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

32 635 570 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

30 354 684 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

21 681 026 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

25.1%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 16.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.012%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

66.316%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

16.498%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

31.5%

Solvency indicators evolution
GETINGE LIFE SCIENCE FRANCE

Sector positioning

Debt ratio
0.01 2024
2022
2023
2024
Q1: 0.81
Med: 21.34
Q3: 62.69
Excellent

In 2024, the debt ratio of GETINGE LIFE SCIENCE FRANCE (0.01) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
66.32% 2024
2022
2023
2024
Q1: 34.69%
Med: 51.42%
Q3: 66.21%
Excellent +9 pts over 3 years

In 2024, the financial autonomy of GETINGE LIFE SCIENCE FRANCE (66.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.67 years
Q3: 2.23 years
Excellent

In 2024, the repayment capacity of GETINGE LIFE SCIENCE FRANCE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 337.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.2x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

337.447

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.153

Liquidity indicators evolution
GETINGE LIFE SCIENCE FRANCE

Sector positioning

Liquidity ratio
337.45 2024
2022
2023
2024
Q1: 149.84
Med: 223.59
Q3: 339.99
Good +22 pts over 3 years

In 2024, the liquidity ratio of GETINGE LIFE SCIENCE FRANCE (337.45) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
0.15x 2024
2022
2023
2024
Q1: 0.29x
Med: 3.95x
Q3: 10.02x
Average

In 2024, the interest coverage of GETINGE LIFE SCIENCE FRANCE (0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 87 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 62 days. The company must finance 25 days of gap between collections and payments. Inventory turnover is 90 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 194 days of revenue, i.e. 70.0 M€ to permanently finance. Over 2016-2024, WCR increased by +943%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

69 965 829 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

87 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

62 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

90 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

194 j

WCR and payment terms evolution
GETINGE LIFE SCIENCE FRANCE

Positioning of GETINGE LIFE SCIENCE FRANCE in its sector

Comparison with sector Fabrication d'emballages en matières plastiques

Valuation estimate

Based on 76 transactions of similar company sales (all years), the value of GETINGE LIFE SCIENCE FRANCE is estimated at 36 058 846 € (range 14 348 094€ - 85 876 061€). With an EBITDA of 32 635 570€, the sector multiple of 1.3x is applied. The price/revenue ratio is 0.20x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
76 tx
14348k€ 36058k€ 85876k€
36 058 846 € Range: 14 348 094€ - 85 876 061€
NAF 4 all-time Aggregated at NAF sub-class level

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
32 635 570 € × 1.3x
Estimation 41 214 594 €
16 439 867€ - 91 505 589€
Revenue Multiple 30%
130 031 091 € × 0.20x
Estimation 26 454 441 €
12 646 523€ - 35 601 172€
Net Income Multiple 20%
21 681 026 € × 1.7x
Estimation 37 576 086 €
11 671 018€ - 147 214 579€
How is this estimate calculated?

This estimate is based on the analysis of 76 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication d'emballages en matières plastiques)

Compare GETINGE LIFE SCIENCE FRANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication d'emballages en matières plastiques

Frequently asked questions about GETINGE LIFE SCIENCE FRANCE

What is the revenue of GETINGE LIFE SCIENCE FRANCE ?

The revenue of GETINGE LIFE SCIENCE FRANCE in 2024 is 130.0 M€.

Is GETINGE LIFE SCIENCE FRANCE profitable?

Yes, GETINGE LIFE SCIENCE FRANCE generated a net profit of 21.7 M€ in 2024.

Where is the headquarters of GETINGE LIFE SCIENCE FRANCE ?

The headquarters of GETINGE LIFE SCIENCE FRANCE is located in VENDOME (41100), in the department Loir-et-Cher.

Where to find the tax return of GETINGE LIFE SCIENCE FRANCE ?

The tax return of GETINGE LIFE SCIENCE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GETINGE LIFE SCIENCE FRANCE operate?

GETINGE LIFE SCIENCE FRANCE operates in the sector Fabrication d'emballages en matières plastiques (NAF code 22.22Z). See the 'Sector positioning' section above to compare the company with its competitors.